Evaluation of Significance of Liver Enzymes as Screening Tests for the Early Detection of Clinically Asymptomatic Non Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.7439/ijbar.v6i12.2803Keywords:
NSAIDS, Thiocolchicoside, DexketoprofenTrometamolAbstract
Background: Type 2 diabetes mellitus has been linked with abnormal liver function tests. Increased activities of liver enzymes such as aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), ?-glutamyl transferase (GGT) are markers of liver cell injury. Increased activity of these markers is associated with metabolic syndrome, insulin resistance and type 2 diabetes mellitus. This study was aimed to evaluate the significance of liver enzymes such as aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), ?-glutamyl transferase (GGT) in type 2 diabetes mellitus patients. Materials and Methods: Total of 108 cases of type 2 diabetes mellitus patients, comprising of 68 males (62.9%) and 40 females (37%) were included in the study. 110 healthy subjects were includes as controls. Age of the subjects ranged between 27 to 75 years. Serum sample was used for the estimation of study parameters such as FBS, PPBS, AST, ALT, ALP, GGT, Total bilirubin, Direct bilirubin, Total proteins and Albumin. Results: In the present study, mean values of AST, ALT, ALP and GGT were statistically significantly increased in type 2 diabetes mellitus patients when compared to controls (P value 0.001). Conclusion: In this study, we found an association between the increased levels of liver enzymes such as AST, ALT, ALP and GGT in type 2 diabetes mellitus patients. Increased levels of ALT and AST are the surrogate markers for associated non alcoholic fatty liver disease in type 2 diabetes mellitus patients. Hence, testing for AST, ALT, ALP, and GGT should be carried out to screen for underlying non alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus patients.Downloads
References
King GL. The role of inflammatory cytokines in the diabetes and its complications. J Periodontal Aug 2008; (1): 1527-1534.
Kumar KPS.Bhowmik D,Srivastava S, Paswan S, DuttaAS. Diabetes epidemic in India-A comprehensive review of clinical features, management and remedies. The pharma innovation 2012; (2):17-33.
Kaku K. Pathophysiology of type 2 diabetes and its treatment policy. Research and reviews, JMAJ 2010; 53(1): 41-46.
Netaji Oration. Diabetes and liver disease. Medicine Update 2010; 20.
Hind M.Elmahi, AbdElkarim A. Abdrabo. Determinants of abnormal liver function tests in Diabetes Type 2 patients in Sudan. Journal of Science 2014; 4(1): 45-49.
A.O.Odewabi, E.G.Akinola,O.A. Ogundahunsi et al., Liver Enzymes and its correlates in treated and newly diagnosed type 2 diabetes mellitus patients in Osogbo, South, West, Nogeria. Asian Journal of Medical Sciences 2013; 5(5): 108-112.
Ayman S.Idris, Koua Faisal Hammad Mekky, Badr Eldin Elsonni Abdalla and Khalid Altom Ali. Liver function tests in type 2 Sudanese diabetic patients. International Journal of Nutrition and Metabolism 2011; 3(2): 17-21.
Raiza Phillip, Michelle Mathias, Sucheta Kumari N, Damodara Gowda K.M, Jayaprakash Shetty K. Evaluation of relationship between markers of liver function and the onset of type 2 diabetes. Nitte University Journal of Health Science 2014; 4(2): 90-93.
Tushar kanti Patra, Rudrajit Paul, Sanjay Kumar Mandal, et al., Liver function tests in type 2 diabetes mellitus patients with and without oral hypoglycaemic agents and statin intake. Indian Medical Gazette 2012;388-393.
IM Paruk, FJ Pirie, AA Motala, BA Kolawole. High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetic clinic. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2011; 16(1): 42-45.
Rajeswari S, Kumar A, Gandhi M, Swaminathan S. Association between Lipid Profile and Liver Function Tests in Diabetic Patients. International Journal of Pure Science & Applied Bioscience 2014; 2(4): 26-31.
Choudhary M, Jinger SK, Gahlot G, Saxena R. Comparative Study of Liver Function Tests in Type-1 and Type-2 Diabetes Mellitus. Indian J,Sci.Res 2014; 5(2): 143-147.
Juhi Agarawal. Prevalence of elevated hepatic enzymes among north Indian patients with type 2 diabetes mellitus. Santosh University Journal of Health Sciences 2015; 1(1): 3-6.
Gonem S, Wall A, Parijat De. Prevalence of abnormal liver function tests in patients diabetes mellitus. Endocrine Abstracts 2007;13:157.
Han Ni, Htoo Htoo Kyaw Soe,Aung Htet. Determinants of Abnormal Liver Function Tests in Diabetes Patients in Myanmar. International Journal of Diabetes Research 2012; 1(3): 36-41.
Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Francesconi P, et al., Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bango a Ripoli (FIBAR) study. Metabolism 2008; 57(3): 387-392.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
